Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Tegunor
2. Tricosal
3. Trilisate
1. 64425-90-7
2. Djj95fjp1h
3. Choline Magnesium Salicylate
4. Cholinemagnesiumtrisalicylate
5. Trisalicylate-choline
6. Tegunor
7. Tricolsal
8. Unii-djj95fjp1h
9. Tricosal (tn)
10. Choline Mixture With Magnesium Salicylate
11. Dtxsid901344133
12. Db01401
13. Nsc 751675
14. D07694
15. Choline Magnesium Trisalicylate [who-dd]
16. Q20817211
17. ((1,2-ethanediylbis(carbamodithioato))(2-))manganese, Mixt. With ((1,2-ethanediylbis(carbamodithioato))(2-))zinc & 2(or 4)-isooctyl-4,6(or 2,6)-dinitrophenyl 2-buten Oate
18. Ethanaminium, 2-hydroxy-n,n,n-trimethyl-, 2-hydroxybenzoate (1:1), Mixt. With (t-4)-bis(2-(hydroxy-.kappa.o)benzoato-.kappa.o)magnesium
19. Ethanaminium, 2-hydroxy-n,n,n-trimethyl-, Salt With 2-hydroxybenzoic Acid (1:1), Mixt. With 2-hydroxybenzoic Acid Magnesium Salt (2:1)
| Molecular Weight | 539.8 g/mol |
|---|---|
| Molecular Formula | C26H29MgNO10 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 5 |
| Exact Mass | 539.1641878 g/mol |
| Monoisotopic Mass | 539.1641878 g/mol |
| Topological Polar Surface Area | 201 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 179 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 5 |
Choline magnesium trisalicylate is used to reduce pain and inflammation caused by conditions such as arthritis. This medication is also used to treat fever in adults.
Trisalicylate-choline is a non-steroidal anti-inflammatory drug (NSAID) that contains a combination of choline salicylate and magnesium salicylate. Does not affect platelet aggregation.
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Route of Elimination
renal
Inhibits prostaglandin synthesis; acts on the hypothalamus heat-regulating center to reduce fever; blocks the generation of pain impulses
ABOUT THIS PAGE
A Trisalicylate-Choline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trisalicylate-Choline, including repackagers and relabelers. The FDA regulates Trisalicylate-Choline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trisalicylate-Choline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Trisalicylate-Choline supplier is an individual or a company that provides Trisalicylate-Choline active pharmaceutical ingredient (API) or Trisalicylate-Choline finished formulations upon request. The Trisalicylate-Choline suppliers may include Trisalicylate-Choline API manufacturers, exporters, distributors and traders.
click here to find a list of Trisalicylate-Choline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trisalicylate-Choline DMF (Drug Master File) is a document detailing the whole manufacturing process of Trisalicylate-Choline active pharmaceutical ingredient (API) in detail. Different forms of Trisalicylate-Choline DMFs exist exist since differing nations have different regulations, such as Trisalicylate-Choline USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trisalicylate-Choline DMF submitted to regulatory agencies in the US is known as a USDMF. Trisalicylate-Choline USDMF includes data on Trisalicylate-Choline's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trisalicylate-Choline USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trisalicylate-Choline suppliers with USDMF on PharmaCompass.
Trisalicylate-Choline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trisalicylate-Choline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trisalicylate-Choline GMP manufacturer or Trisalicylate-Choline GMP API supplier for your needs.
A Trisalicylate-Choline CoA (Certificate of Analysis) is a formal document that attests to Trisalicylate-Choline's compliance with Trisalicylate-Choline specifications and serves as a tool for batch-level quality control.
Trisalicylate-Choline CoA mostly includes findings from lab analyses of a specific batch. For each Trisalicylate-Choline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trisalicylate-Choline may be tested according to a variety of international standards, such as European Pharmacopoeia (Trisalicylate-Choline EP), Trisalicylate-Choline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trisalicylate-Choline USP).
LOOKING FOR A SUPPLIER?
